Lumbar Erector Spinae Plane Block in Knee Prosthesis

NCT ID: NCT04544423

Last Updated: 2020-09-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

34 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-02

Study Completion Date

2021-09-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the postoperative analgesic efficiency of ultrasound-guided lumbar erector spinae plane block, patients are divided into two groups. Study group received ultrasound-guided lumbar erector spinae plane block, where control had none. Visual analog scale and opioid consumption are recorded.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Erector spinae plane block has successfully been demonstrated to provide an efficient analgesia in patients with rib fracture, open thoracotomy, breast surgery. The present study is aimed to investigate the intraoperative hemodynamic responses, anesthetic and analgesic consumption, and postoperative recovery quality of erector spinae plane block in patients with knee prosthesis. After approval, patients enrolled in the study are divided into two groups by computer-based randomization technique as control and study group. After standard monitorization, anesthesia induction and tracheal intubation, erector spinae plane block is performed to study group and no intervention to control group.

In the intraoperative period, 10 mg / kg paracetamol and 0.05 mg / kg morphine will be used for postoperative analgesia. After surgery, all patients will be given 10 mg/kg paracetamol every 8 hours and will be fitted with a patient-controlled analgesia (PCA) device (Tramadol HCL). PCA device bolus dose will be set to 20 mg, lock time will be set to 10 minutes and the number of buttons per hour will be set as 3.for postoperative analgesia.After surgery, VAS scores of the patients will be evaluated (in the recovery room, 1,3,6,12 and 24 hours, Patients with VAS≥4 will be given 0.03mg / kg morphine as salvage analgesia.After 30 minutes, the patients' VAS will be re-evaluated,If VAS≥4 the same dose will be repeated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Block group

Patients received lumbar erector spinae plane Block before operation

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Control group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Over 18 years of age Planned to knee prosthesis An American Society of Anesthesiologists score of 1,2 or 3

Exclusion Criteria

Severe cardiovascular disease Psychiatric diseases Rejected to participation Those who have chronic pain
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tokat Gaziosmanpasa University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hakan Tapar

Tokat Gaziosmanpasa University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hakan Tapar

Role: PRINCIPAL_INVESTIGATOR

Gaziosmanpasa University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gaziosmanpasa University

Tokat Province, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hakan Tapar

Role: CONTACT

03562129500 ext. 3495

Serkan Karaman

Role: CONTACT

03562129500 ext. 3495

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19-KAEK-129

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

USG Guided ESP Block in Spinal Surgery
NCT04148729 COMPLETED PHASE4